Serial EntrepreneurAbout
Advanced proteomic diagnostics company deploying liquid biopsy technology for true early detection of all cancers through screening and monitoring. The company offers a proprietary blood test measuring unique expression of oncogenic protein levels to detect cancer presence, stage, and distinguish between benign and malignant conditions with over 90% sensitivity.
Traction & Metrics
Financial
$0
MRR
$0
ARR
Products
MPS-1 Cancer Screening Test
Revolutionary liquid biopsy blood test that measures MPS-1 (Metallopanstimulin-1) protein levels to screen for and monitor all cancer types. Delivers 24-hour results with over 90% sensitivity, detecting early stage 1-2 cancers, distinguishing between benign and malignant conditions, and providing stage distinction. Requires only 5ml blood sample compared to competitors' 20-34ml. Offers quantitative and qualitative data for precision monitoring and guidance at $400 per test, significantly less than competitors at $689-$950.
Click to read more
Updates
Laboratory Buildout site selected.
Laboratory location within 2 miles of the Medical Cortex and Siteman a Major NCCN hospital was identified and confirmed with realtors.